Cardiomyopathy is a leading cause of heart failure in children, and there are currently no effective treatments. Could emerging therapies that successfully target the root cause of the condition in adults also work well in children? That was the question Dr....
In the realm of cardiac health, an exciting new study has cast light on the intricate details of our hearts, revealing significant differences between the left and right ventricles' fibroblasts. This research, conducted by a team of dedicated scientists from the...
For children diagnosed with complex heart conditions like hypertrophic cardiomyopathy (HCM), the diagnosis can be frightening for families and challenging for healthcare providers since the trajectory of the condition is often uncertain. As a leading cause of sudden...
An innovative cardiovascular start-up, HDAX Therapeutics, is the latest company to win $250,000 in funding following another year of the Ted Rogers Centre for Heart Research’s Entrepreneurship for Cardiovascular Health Opportunities (ECHO) program. The ECHO program...
Several members of the Ted Rogers Centre for Heart Research (TRCHR) participated in Vascular 2023, a five-day conference held in Montreal from October 25-29. The conference is a hallmark event organized by several Canadian specialist and research organizations,...
Researchers at the Ted Rogers Centre for Heart Research have developed an innovative approach to better understanding the complex signaling mechanisms underlying heart failure. A recent publication in the Proceedings of the National Academy of Sciences (PNAS) offers...
The 11th World Congress for Microcirculation (WCM2018) will be held in Vancouver, BC, Canada from September 9-13, 2018. This marks the first return of the Congress to Canada since its inaugural meeting in Toronto in 1975.
The Congress is organized and held on a rotating 3-5 year basis in a unique location corresponding to a regional Microcirculation Society. Since 1975 the meeting has attracted on average 600 delegates from regional Microcirculation Societies from around the world, including Japan, China, Australia and New Zealand, North America, Britain, and the European Union.
The theme of the Congress is microcirculation in health and disease with a focus on emerging research and technologies. Its objective is to advance research and education in the many areas of microcirculation. With strong representation from the International Scientific Advisory Committee, with representatives from England, Europe, North and South America and the Pacific Rim, the Local Organizing Committee has developed an exciting meeting which reflects the growing research areas of microcirculation and the pivotal role these fields play in translational applications. Congress symposia will include inflammation, permeability, vascular control and angiogenesis, to name a few.
The microcirculation is required for all vital and non-vital organs as part of a healthy body. It supplies oxygen and nutrients and is integral to the removal of metabolic waste. Due to its critical importance to general health, the commercial and industrial applications include development of new drugs and therapies, and treatment of a wide range of human diseases, including vascular and perivascular disease, diabetes, stroke, dementia, cancer and sepsis.